FREDUN PHARMACEUTICALS
Back to All Ratios
|
FREDUN PHARMACEUTICALS Last 5 Year Asset Turnover History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| Asset Turnover(x) | 1.13 | 0.93 |
What is the latest Asset Turnover ratio of FREDUN PHARMACEUTICALS ?
| Year | Asset Turnover |
|---|---|
| Mar2026 | 1.13 |
| Mar2025 | 0.93 |
How is Asset Turnover of FREDUN PHARMACEUTICALS Trending?
| Years | Asset Turnover | % Change | |
|---|---|---|---|
| Mar2026 | 1.13 | 21.51 | |
| Mar2025 | 0.93 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Asset Turnover ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,831.1 Cr | 22.3% | 31.2% | 242.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 22.3% |
31.2% |
242.5% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses